Guangzhou Baiyunshan Phar... (GZPHF)

PNK: GZPHF · Real-Time Price · USD

2.44

0.19 (8.44%)

At close: May 02, 2025, 1:42 PM

Guangzhou Baiyunshan Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	18.27B	21.31B	22.5B	22.38B	19.47B	18.47B	16.11B	11.7B	13.09B
Short-Term Investments	10.2B	4M	56.87M	-349.26M	4M	-337.49M	-322.4M	4.88M	6.03M
Long-Term Investments	2.00	9.62B	5.84B	3.24B	2.75B	2.28B	2.39B	3.04B	2.61B
Other Long-Term Assets	10.74B	278.43M	672.66M	168.48M	490.89M	289.54M	2.58M	271.62M	308.51M
Receivables	20.45B	19.6B	19.17B	17.21B	15.69B	17.22B	13.65B	3.77B	2.71B
Inventory	12.81B	11.51B	10.67B	10.44B	9.76B	9.49B	9.23B	3.7B	2.78B
Other Current Assets	5.65B	2.84B	2.55B	2.79B	2.42B	17.35B	2.49B	5.85B	894.37M
Total Current Assets	57.76B	55.98B	57.06B	52.81B	47.4B	45.98B	43.03B	21.5B	19.51B
Property-Plant & Equipment	7.94B	7.51B	6.57B	5.68B	5.1B	4.43B	3.65B	2.37B	2.36B
Goodwill & Intangibles	4.03B	4.03B	3.66B	3.42B	3.28B	3.31B	1.84B	740.31M	682.82M
Total Long-Term Assets	23.92B	22.6B	17.6B	13.31B	12.36B	10.91B	8.45B	6.81B	6.38B
Total Assets	81.68B	78.59B	74.67B	66.12B	59.76B	56.89B	51.48B	28.31B	25.9B
Account Payables	16.32B	15.69B	8.74B	14.73B	14.16B	13.68B	11.97B	3.05B	2.59B
Deferred Revenue	n/a	n/a	5.64B	8.5B	6.43B	8.99B	963.54M	3.28B	3.26B
Short-Term Debt	9.12B	7.8B	9.64B	8.43B	8.27B	5.87B	6.11B	42.81M	25.22M
Other Current Liabilities	7.25B	6.38B	11.78B	6.35B	392.09M	5.15B	7.91B	1.89B	1.55B
Total Current Liabilities	38.92B	36.24B	37.4B	32.25B	29.24B	29.38B	26.95B	8.27B	7.42B
Long-Term Debt	2.81B	3.32B	1.64B	752.81M	497.55M	4.5M	413.55M	20.17M	33.5M
Other Long-Term Liabilities	119.61M	1.13B	121.76M	128.17M	181.76M	132.97M	728.25M	120.85M	98.76M
Total Long-Term Liabilities	5B	5.67B	3.63B	2.54B	2.31B	1.53B	1.39B	782.71M	820.93M
Total Liabilities	43.91B	41.91B	41.03B	34.79B	31.55B	30.9B	28.34B	9.05B	8.24B
Total Debt	12.37B	11.7B	11.43B	9.92B	9.56B	6.65B	6.52B	42.81M	58.72M
Common Stock	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B
Retained Earnings	21.82B	20.96B	18.26B	15.59B	12.93B	11.17B	8.83B	6.29B	4.78B
Comprehensive Income	n/a	-24.34M	3.13B	2.8B	2.54B	2.34B	2.19B	1.96B	1.88B
Shareholders Equity	35.9B	34.92B	32.07B	29.06B	26.14B	24.18B	21.68B	18.87B	17.35B
Total Investments	10.2B	9.45B	5.9B	2.89B	2.75B	1.94B	2.07B	3.05B	2.62B